Nicotine and estrogen metabolism--possible implications of smoking for growth and outcome of treatment of hormone-dependent cancer? Discussion of experimental results

J Cancer Res Clin Oncol. 1989;115(6):601-3. doi: 10.1007/BF00391366.

Abstract

The combination treatment of hormone-dependent autochthonous mammary carcinomas in the rat with nicotine plus HECNU, a water-soluble nitrosourea, resulted in a potentiation of antitumor action. Nicotine and its metabolite cotinine are strong inhibitors of the aromatase. With regard to investigations in smoking women, suggesting a decreased endogenous estrogen production, our results indicate that smoking might influence growth and treatment results of hormone-dependent human cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aromatase / metabolism
  • Chemical Phenomena
  • Chemistry
  • Drug Synergism
  • Estrogens / metabolism*
  • Estrogens / pharmacology
  • Female
  • Humans
  • Mammary Neoplasms, Experimental / drug therapy
  • Mammary Neoplasms, Experimental / metabolism*
  • Mammary Neoplasms, Experimental / pathology
  • Microsomes / drug effects
  • Microsomes / enzymology
  • Neoplasms, Hormone-Dependent / drug therapy
  • Neoplasms, Hormone-Dependent / metabolism*
  • Neoplasms, Hormone-Dependent / pathology
  • Nicotine / metabolism
  • Nicotine / pharmacology*
  • Rats
  • Smoking / metabolism*

Substances

  • Estrogens
  • Nicotine
  • Aromatase